484 712

Cited 20 times in

Knock-down of human MutY homolog (hMYH) decreases phosphorylation of checkpoint kinase 1 (Chk1) induced by hydroxyurea and UV treatment

DC Field Value Language
dc.contributor.author정지형-
dc.date.accessioned2014-12-20T17:12:06Z-
dc.date.available2014-12-20T17:12:06Z-
dc.date.issued2011-
dc.identifier.issn1976-6696-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/94149-
dc.description.abstractThe effect of human MutY homolog (hMYH) on the activation of checkpoint proteins in response to hydroxyurea (HU) and ultraviolet (UV) treatment was investigated in hMYH-disrupted HEK293 cells. hMYH-disrupted cells decreased the phosphorylation of Chk1 upon HU or UV treatment and increased the phosphorylation of Cdk2 and the amount of Cdc25A, but not Cdc25C. In siMYH-transfected cells, the increased rate of phosphorylated Chk1 upon HU or UV treatment was lower than that in siGFP-transfected cells, meaning that hMYH was involved in the activation mechanism of Chk1 upon DNA damage. The phosphorylation of ataxia telangiectasia and Rad3- related protein (ATR) upon HU or UV treatment was decreased in hMYH-disrupted HEK293 and HaCaT cells. Co-immunoprecipitation experiments showed that hMYH was immunoprecipitated by anti-ATR. These results suggest that hMYH may interact with ATR and function as a mediator of Chk1 phosphorylation in response to DNA damage-
dc.description.statementOfResponsibilityopen-
dc.format.extent352~357-
dc.relation.isPartOfBMB REPORTS-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAnimals-
dc.subject.MESHAtaxia Telangiectasia Mutated Proteins-
dc.subject.MESHCell Cycle Proteins/genetics-
dc.subject.MESHCell Cycle Proteins/metabolism-
dc.subject.MESHCell Line-
dc.subject.MESHCheckpointKinase1-
dc.subject.MESHDNA Damage/drug effects-
dc.subject.MESHDNA Glycosylases/genetics-
dc.subject.MESHDNA Glycosylases/metabolism*-
dc.subject.MESHEnzyme Inhibitors/pharmacology-
dc.subject.MESHGene Knockdown Techniques-
dc.subject.MESHHumans-
dc.subject.MESHHydroxyurea/pharmacology*-
dc.subject.MESHPhosphorylation/drug effects*-
dc.subject.MESHPhosphorylation/radiation effects*-
dc.subject.MESHProtein Kinases/genetics-
dc.subject.MESHProtein Kinases/metabolism*-
dc.subject.MESHProtein-Serine-Threonine Kinases/genetics-
dc.subject.MESHProtein-Serine-Threonine Kinases/metabolism-
dc.subject.MESHRNA, Small Interfering/genetics-
dc.subject.MESHRNA, Small Interfering/metabolism-
dc.subject.MESHUltraviolet Rays*-
dc.titleKnock-down of human MutY homolog (hMYH) decreases phosphorylation of checkpoint kinase 1 (Chk1) induced by hydroxyurea and UV treatment-
dc.typeArticle-
dc.contributor.collegeResearcher Institutes (부설 연구소)-
dc.contributor.departmentResearch Institute for Cerebral & Cardiovascular Diseases (심혈관제품유효성평가센터)-
dc.contributor.googleauthorSoo-Hyun Hahm-
dc.contributor.googleauthorJong-Hwa Park-
dc.contributor.googleauthorSung Il Ko-
dc.contributor.googleauthorYou Ri Lee-
dc.contributor.googleauthorIn Sik Chung-
dc.contributor.googleauthorJi Hyung Chung-
dc.contributor.googleauthorLin-Woo Kang-
dc.contributor.googleauthorYe Sun Han-
dc.identifier.doi10.5483/BMBRep.2011.44.5.352-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA03739-
dc.relation.journalcodeJ00348-
dc.identifier.eissn1976-670X-
dc.identifier.pmid21615992-
dc.subject.keywordAtaxia telangiectasia and Rad3-related protein (ATR)-
dc.subject.keywordCheckpoint kinase 1 (Chk1)-
dc.subject.keywordHuman MutY homolog (hMYH)-
dc.subject.keywordHydroxyurea (HU)-
dc.subject.keywordUltraviolet (UV)-
dc.contributor.alternativeNameChung, Ji Hyung-
dc.contributor.affiliatedAuthorChung, Ji Hyung-
dc.rights.accessRightsfree-
dc.citation.volume44-
dc.citation.number5-
dc.citation.startPage352-
dc.citation.endPage357-
dc.identifier.bibliographicCitationBMB REPORTS, Vol.44(5) : 352-357, 2011-
Appears in Collections:
1. College of Medicine (의과대학) > Research Institute (부설연구소) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.